Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
22 results
D1.169 - Monitoring of pulmonary function in pregnant women with severe asthma controlled in a monographic asthma and pregnancy unit
D1.154 - Mepolizumab treatment in a patient with severe eosinophilic granulomatosis with polyangiitis: a case report
D1.155 - Clinical, Functional and Inflammatory Characteristics of Young Adults with Bronchial Asthma Using Conventional Cigarettes, Electronic Nicotine Delivery Systems and Heated Tobacco Products
D1.156 - High relevance of upper airways comorbidities in T2 asthma inflammatory burden
D1.157 - Response to biologic therapy in severe asthma and chronic rhinosinusitis with nasal polyps according to nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity
D1.159 - Comorbidity of Asthma in Chronic Spontaneous Urticaria: Prevalence and Immunological Insights from a Sri Lankan Cohort
D1.160 - Perceptions, Attitudes, and Real-World Use of FENO in Allergy and Asthma Practice: Results of a National Survey from Türkiye
D1.161 - Clinical-epidemiological profile of pediatric difficult-to-control asthma in a tertiary referral center in Brazil
D1.164 - Evaluation of the use of cyclooxygenase-2 inhibitors in patients with AERD
D1.165 - Asthma Predisposition and miRNA Expression in Children with Recurrent Infections
D1.166 - REX-8756 is a First-in-Class Potent and Selective Orthosteric STAT6 Inhibitor That Demonstrates Efficacious Potential and Safety Differentiation in TH2-Mediated Inflammation
D1.168 - ASSOCIATION BETWEEN MOLECULAR ALLERGEN SENSITIZATION AND FeNO IN CHILDREN WITH ALLERGIC ASTHMA
D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies
D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection
D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper
D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use
D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD
D2.456 - Chronic sinusitis with nasal polyposis: Add-on aspirin desensitization useful in dupilumab therapy?
D2.461 - Endothelial related miRs are dysregulated in C1-INH Angioedema patients: new potential biomarkers and therapeutic targets
D2.462 - Safety and predictors of tolerance in rituximab hypersensitivity management
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download